Literature DB >> 9539486

Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms.

E Hoffmann1, P Assennato, M Donatelli, I Colletti, T M Valenti.   

Abstract

BACKGROUND: Some patients with typical angina and electrocardiographic evidence of ischemia have normal coronary angiograms. These patients have a reduced coronary flow reserve and abnormal endothelium-dependent vasodilator responses; this syndrome is known as microvascular angina. Among endothelium-derived peptides, endothelin-1 (ET-1) is a potent vasoconstrictor and an important modulator of microvascular function.
METHODS: Plasma ET-1 was measured in 13 patients with typical angina, instrumental evidence of ischemia, and normal arteriograms and in 20 normal control subjects.
RESULTS: Mean concentration of ET-1 was 2.89+/-1.24 pmol/L in patients with angina and normal angiograms and 1.99+/-0.81 pmol/L in normal control subjects (p < 0.02). Plasma levels of ET-1 values were significantly higher in patients with angina, positive exercise test results for ischemia, and normal coronary arteriograms compared with the group of patients with no clinical or instrumental evidence of ischemia.
CONCLUSIONS: This is consistent with the hypothesis that in patients with microvascular angina, an endothelial dysfunction in the coronary vascular area caused by impaired endothelium-derived ET-1 could play an active role in the disease process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539486     DOI: 10.1016/s0002-8703(98)70286-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries.

Authors:  J Sztajzel; F Mach; A Righetti
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

2.  Angina in Women without Obstructive Coronary Artery Disease.

Authors:  Kamakki Banks; Monica Lo; Amit Khera
Journal:  Curr Cardiol Rev       Date:  2010-02

3.  Endothelin-1 impairs coronary arteriolar dilation: Role of p38 kinase-mediated superoxide production from NADPH oxidase.

Authors:  Naris Thengchaisri; Travis W Hein; Yi Ren; Lih Kuo
Journal:  J Mol Cell Cardiol       Date:  2015-07-23       Impact factor: 5.000

4.  Novel biomarkers of coronary microvascular disease.

Authors:  Olivia Y Hung; Suegene K Lee; Parham Eshtehardi; Habib Samady
Journal:  Future Cardiol       Date:  2016-06-13

5.  Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Wilmer W Nichols; Scott J Denardo; Jonathan B Davidson; Tianyao Huo; C Noel Bairey Merz; Carl J Pepine
Journal:  Am Heart J       Date:  2015-08-28       Impact factor: 4.749

Review 6.  Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview.

Authors:  Guihua Tian; Yang Sun; Shuo Liu; Chengyu Li; Shiqi Chen; Ruijin Qiu; Xiaoyu Zhang; Youping Li; Min Li; Hongcai Shang
Journal:  Front Pharmacol       Date:  2018-09-05       Impact factor: 5.810

Review 7.  The Biochemical Markers Associated with the Occurrence of Coronary Spasm.

Authors:  Liang Li; Yong-Ping Jin; Shu-Dong Xia; Chao Feng
Journal:  Biomed Res Int       Date:  2019-09-17       Impact factor: 3.411

8.  Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy.

Authors:  Shu-Huai Tsai; Guangrong Lu; Xin Xu; Yi Ren; Travis W Hein; Lih Kuo
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787

9.  Impact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 Rats.

Authors:  Devi Ganesh; Prem Kumarathasan; Errol M Thomson; Carly St-Germain; Erica Blais; James Crapo; Renaud Vincent
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.